Betnovate N Cream: Uses, Side Effects, How to Apply & Complete Guide

✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Last updated: April 10, 2026

Betnovate N Cream is one of the most widely prescribed topical corticosteroid-antibiotic combinations in dermatology. Combining the anti-inflammatory power of betamethasone valerate with the antibacterial action of neomycin sulphate, it treats skin conditions where both inflammation and bacterial infection are present.

Whether your doctor has prescribed Betnovate N for infected eczema, bacterial dermatitis, or another condition complicated by infection, understanding how it works, how to apply it correctly, and what side effects to watch for is essential for safe treatment.

This comprehensive guide covers all three Betnovate variants — Betnovate (plain), Betnovate N, and Betnovate C — so you can understand exactly which formulation is right for your condition and how to use it safely.

What Is Betnovate N Cream?

Betnovate N Cream is a prescription-strength topical medication manufactured by GlaxoSmithKline (GSK) combining two active ingredients:

• Betamethasone valerate 0.1% w/w — a potent (Group III) topical corticosteroid that rapidly reduces inflammation, redness, swelling, and itching by suppressing the release of inflammatory mediators in the skin.
• Neomycin sulphate 0.5% w/w — an aminoglycoside antibiotic that kills or inhibits the growth of susceptible bacteria commonly found on infected skin, including Staphylococcus aureus and many Gram-negative organisms.

The “N” in Betnovate N simply stands for Neomycin, indicating the presence of this antibiotic component. This distinguishes it from plain Betnovate (betamethasone only) and Betnovate C (betamethasone plus clioquinol, an antifungal/antibacterial agent).

This dual-action formula is valuable because many inflammatory skin conditions are frequently complicated by secondary bacterial infection. Scratching damaged skin creates entry points for bacteria, fueling a cycle of infection, inflammation, itching, and more scratching. Betnovate N breaks this cycle by addressing both problems simultaneously.

Betnovate Variants Compared

GSK manufactures three Betnovate formulations, each designed for different clinical scenarios. Understanding the differences helps you and your doctor choose the right one for your specific condition.

If your skin condition is inflamed but not infected, plain Betnovate Cream may be sufficient. If there are signs of bacterial infection — weeping, crusting, pus, or spreading redness — Betnovate N is typically the better choice. If fungal infection is suspected (common in warm, moist skin folds), Betnovate C with its antifungal clioquinol component is preferred.

Betnovate N Cream Uses

Betnovate N Cream is indicated for the treatment of inflammatory skin conditions where bacterial infection is present, suspected, or likely to occur. Below are the most common clinical uses, with an explanation of how the betamethasone-neomycin combination works in each scenario.

Eczema with Secondary Bacterial Infection

Eczema (atopic dermatitis) is the most common reason doctors prescribe Betnovate N. Up to 90% of eczema patients have Staphylococcus aureus colonization on their skin, and active infection is a frequent trigger for eczema flares. Signs of infected eczema include weeping, crusting, yellow discharge, and increased redness spreading beyond the original eczema patches.

In this scenario, betamethasone calms the inflammatory eczema response — reducing redness, swelling, and the intense itch that drives the scratch-itch cycle — while neomycin eliminates the bacterial component that is perpetuating or worsening the flare.

Infected Contact Dermatitis

Contact dermatitis presents as inflamed, itchy skin at the site of exposure to an allergen or irritant. When scratching breaks the skin barrier, bacteria can colonize the area. Betnovate N addresses the inflammatory response and clears the superimposed infection simultaneously, allowing the skin to heal more quickly than either component alone.

Psoriasis with Bacterial Superinfection

While psoriasis is primarily an immune-mediated condition, the thickened, cracked plaques can become secondarily infected, particularly in flexural areas (skin folds) where moisture and friction create ideal conditions for bacterial growth. Betnovate N can be used for short courses in these situations, though long-term psoriasis management typically requires different strategies.

Intertrigo

Intertrigo is inflammation of skin folds — under the breasts, in the groin creases, between the toes, and in the axillae (armpits). These warm, moist environments are prone to both bacterial overgrowth and inflammatory irritation. When the intertrigo has a clear bacterial component (as opposed to a fungal cause, which would call for Betnovate C instead), Betnovate N reduces the inflammation and eliminates the bacterial infection.

Otitis Externa (Outer Ear Infection)

Betnovate N is sometimes prescribed for inflammatory conditions of the outer ear canal, where bacterial infection accompanies eczematous changes. The betamethasone reduces canal swelling and discomfort while neomycin targets the causative bacteria. This use should be under direct medical supervision, and the cream should never be used if there is a perforated eardrum, as neomycin is ototoxic and can cause hearing damage if it reaches the middle ear.

Insect Bites with Secondary Infection

Insect bites naturally trigger an inflammatory response — the familiar red, itchy bump. Scratching these bites, especially in warm climates, commonly introduces bacteria through the broken skin, leading to secondary infection characterized by increased swelling, warmth, and sometimes pus formation. Betnovate N reduces the inflammatory itch response and clears the local bacterial infection, breaking the scratch-infection cycle.

How to Apply Betnovate N Cream

Correct application technique is important for both effectiveness and minimizing side effects. Using too much or applying incorrectly increases the likelihood of adverse effects.

Step-by-Step Application

1. Wash and dry your hands thoroughly before application.
2. Clean the affected area gently with lukewarm water and pat dry. Do not rub damaged or infected skin vigorously.
3. Apply a thin layer of Betnovate N Cream to the affected area only. Do not apply to surrounding healthy skin.
4. Rub in gently until the cream is absorbed. There should be no visible white residue remaining.
5. Wash your hands again after application (unless your hands are the area being treated).
6. Do not cover the area with airtight dressings or bandages unless your doctor specifically instructs you to do so. Occlusion dramatically increases steroid absorption and the risk of side effects.

Frequency

The standard recommendation is to apply Betnovate N Cream twice daily — once in the morning and once in the evening. As the condition improves, your doctor may reduce the frequency to once daily. Never apply more frequently than prescribed in an attempt to speed healing; this increases side effect risk without improving outcomes.

The Fingertip Unit (FTU) Guide

A fingertip unit is the amount of cream squeezed from a standard tube along an adult’s fingertip, from the tip to the first crease. One FTU is approximately 0.5 grams and covers an area roughly the size of two adult flat hands (palms plus fingers). Use this as a guide to avoid over-application:

Areas to Avoid

• Eyes and eyelids — betamethasone can cause glaucoma and cataracts with prolonged periocular use.
• Open wounds or deep cuts — neomycin can be absorbed systemically through broken skin, increasing the risk of ototoxicity and nephrotoxicity.
• Large body surface areas — applying potent steroids over extensive areas increases systemic absorption and the risk of HPA axis suppression.
• Under occlusive dressings (unless prescribed) — occlusion multiplies steroid absorption by up to 10-fold.
• Mucosal surfaces — do not apply inside the mouth, nose, or genital mucosa.

Dosage & Duration

Betnovate N Cream is classified as a potent topical corticosteroid (Group III on the WHO/European scale, Group III on the US scale). Duration of use should always be limited to the shortest time necessary to bring the condition under control. Below are general guidelines by condition and body area.

Important warnings about duration:

• Face and genitals: Do not use for longer than 2 weeks on these areas. The skin here is thinner and absorbs steroids at a much higher rate, significantly increasing the risk of skin atrophy, telangiectasia (visible blood vessels), and steroid-induced rosacea.
• Children: Use the shortest duration possible. Children have a higher body-surface-area-to-weight ratio, which means proportionally greater systemic absorption. Treatment courses should not exceed 5–7 days without specialist review.
• Do not stop abruptly after prolonged use on large areas. Gradual tapering (reducing frequency from twice daily to once daily, then every other day) helps prevent rebound flares.

Side Effects

Like all potent topical corticosteroids, Betnovate N Cream carries a risk of side effects, particularly with prolonged use, use on thin-skinned areas, or application under occlusion. The neomycin component adds specific risks related to antibiotic sensitivity and, rarely, systemic absorption.

When to seek medical attention: Contact your doctor if you experience worsening of your skin condition, signs of allergic reaction (increased redness, blistering, or swelling at the application site), or any visual disturbances during treatment.

Precautions & Warnings

Betnovate N Cream is a powerful medication that requires careful use. The following precautions should be observed to minimize risks and ensure the best possible treatment outcome.

Do NOT Use Betnovate N For

• Fungal infections (ringworm, athlete’s foot, candida) — The steroid component suppresses the local immune response, allowing fungal infections to spread rapidly. This is one of the most common misuse scenarios. If fungal infection is present, Betnovate C Cream (with clioquinol) or a dedicated antifungal is needed instead.
• Acne vulgaris — Steroids can initially appear to reduce acne inflammation, but they cause steroid acne and rebound flares on discontinuation. Betnovate N is not an acne treatment.
• Rosacea — Potent steroids worsen rosacea dramatically. Initial improvement is followed by severe rebound with papules, pustules, and telangiectasia (steroid rosacea).
• Perioral dermatitis — Steroids are a known cause and aggravating factor of perioral dermatitis. Use will create a dependency cycle where the condition flares each time the steroid is withdrawn.
• Viral skin infections (herpes simplex, chickenpox, shingles) — The immunosuppressive action of the steroid allows viral infections to spread and worsen.
• Untreated bacterial infections extending beyond mild secondary infection — Deep or spreading skin infections (cellulitis, impetigo covering large areas) require systemic antibiotics, not topical neomycin alone.

Special Populations

• Children under 1 year: Not recommended without specialist dermatologist supervision. Infants have a high body-surface-area-to-weight ratio, thin skin, and underdeveloped metabolic pathways, all of which increase the risk of systemic side effects.
• Elderly patients: Skin becomes thinner with age, increasing susceptibility to steroid-induced atrophy. Use the minimum effective amount for the shortest duration.
• Pregnancy (Category C): Betamethasone crosses the placenta. Animal studies have shown teratogenic effects (including cleft palate) with topical corticosteroids. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus, and only under medical supervision. Avoid large areas, prolonged use, or occlusion.
• Breastfeeding: It is not known whether topical betamethasone or neomycin is excreted in breast milk. If treatment is necessary, do not apply to the breast area, and use the minimum effective amount for the shortest duration.

Drug Interactions

• Other topical corticosteroids: Using Betnovate N alongside other steroid creams on the same area compounds the steroid dose and side effect risk.
• Systemic aminoglycosides (gentamicin, tobramycin): Additional neomycin from topical application through broken skin can contribute to cumulative ototoxicity and nephrotoxicity.
• Topical retinoids: Tretinoin and similar retinoids increase skin irritation and steroid absorption due to their barrier-disrupting effect.
• Emollients: Wait at least 15–30 minutes between applying a moisturizer and Betnovate N to prevent dilution and altered absorption.

Betnovate Products at MedsBase

All three Betnovate variants are available for purchase at MedsBase. Each product is genuine GSK-manufactured Betnovate shipped in original sealed packaging.

Frequently Asked Questions

What is Betnovate N Cream used for?

Betnovate N Cream is used to treat inflammatory skin conditions that have a bacterial infection component. The most common uses include infected eczema, infected contact dermatitis, psoriasis with bacterial superinfection, intertrigo, otitis externa, and infected insect bites. The cream combines a potent corticosteroid (betamethasone) to reduce inflammation and itching with an antibiotic (neomycin) to clear the bacterial infection.

Can I use Betnovate N on my face?

Betnovate N can be used on the face, but only for short courses of 5–7 days, not exceeding 2 weeks. Facial skin is significantly thinner, absorbs more steroid, and is more vulnerable to side effects including skin thinning, telangiectasia, and steroid-induced rosacea. Your doctor may recommend a milder steroid for facial conditions.

What is the difference between Betnovate and Betnovate N?

Plain Betnovate Cream contains only betamethasone valerate 0.1% (a potent corticosteroid), while Betnovate N contains betamethasone valerate 0.1% plus neomycin sulphate 0.5% (an antibiotic). The key distinction: Betnovate N should be chosen when bacterial infection is present alongside inflammation, while plain Betnovate is sufficient for non-infected inflammatory conditions.

Is Betnovate N a steroid cream?

Yes. Betnovate N contains betamethasone valerate, which is classified as a potent topical corticosteroid. It also contains the antibiotic neomycin, making it a combination steroid-antibiotic cream. As with all potent steroids, it should be used for the shortest duration necessary and not applied to large body areas or under occlusive dressings without medical supervision.

How long can I use Betnovate N Cream?

Treatment duration depends on the condition and body area. General guidelines are 7–14 days for body skin and 5–7 days for the face and skin folds, with an absolute maximum of 4 weeks for any body area. Prolonged use increases the risk of skin thinning, stretch marks, and systemic steroid absorption. If your condition has not improved within 7 days, consult your doctor rather than continuing to apply the cream.

Can Betnovate N be used for acne?

No. Betnovate N should not be used for acne. While the anti-inflammatory steroid may initially appear to reduce acne redness and swelling, it causes “steroid acne” with prolonged use and severe rebound flares when discontinued. The neomycin component is also ineffective against Cutibacterium acnes, the primary bacterium involved in acne. For effective acne treatments, see our guide on salicylic acid for acne or explore creams for pimples and dark spots.

Is Betnovate N safe during pregnancy?

Betnovate N is pregnancy category C. Animal studies have shown teratogenic effects with topical corticosteroids, but there are no adequate studies in pregnant women. Use during pregnancy only if the benefit clearly outweighs the risk, under medical supervision, avoiding large treatment areas, prolonged use, or occlusive dressings.

Can I use Betnovate N for dark spots?

No. Betnovate N is not indicated for treating hyperpigmentation or dark spots and should not be used for this purpose. While the steroid can cause depigmentation (skin lightening) as a side effect, this effect is unpredictable, often patchy, and comes with the risk of permanent skin damage including thinning and stretch marks. Dedicated depigmenting agents such as hydroquinone, azelaic acid, or vitamin C serums are far safer and more effective for dark spots.

What happens if I use Betnovate N for too long?

Prolonged use causes increasingly serious side effects. In the short term (weeks to months), expect skin thinning, easy bruising, and visible blood vessels. Over months, irreversible stretch marks can form, particularly in flexural areas. With extended use over large areas, systemic absorption can suppress the HPA axis, leading to adrenal insufficiency. Prolonged neomycin use also increases the risk of contact allergy and promotes antibiotic-resistant bacteria.

Can I buy Betnovate N without a prescription?

Betnovate N is a prescription medication in most countries, including the UK, EU, and Australia, because it contains a potent corticosteroid. However, availability and prescription requirements vary by jurisdiction. At MedsBase, Betnovate N Cream is available for purchase with a straightforward ordering process. Regardless of how you obtain it, we strongly recommend using Betnovate N only under appropriate medical guidance to ensure safe and effective treatment.

Related Guides

Explore more in-depth guides on related skin care topics:

• Betnovate C Cream: Uses, Dosage & Side Effects — Complete guide to the antifungal Betnovate variant
• Best Cream for Pimples and Dark Spots — Evidence-based options for acne and hyperpigmentation
• Can Salicylic Acid Help Treat Acne? — How this BHA works against breakouts

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.